UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042202
Receipt number R000048171
Scientific Title Body mass index and medication utilization in migraine
Date of disclosure of the study information 2020/10/22
Last modified on 2023/08/28 12:49:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Body mass index and medication utilization in migraine

Acronym

Body mass index and medication utilization in migraine

Scientific Title

Body mass index and medication utilization in migraine

Scientific Title:Acronym

Body mass index and medication utilization in migraine

Region

Japan


Condition

Condition

migraine

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the relationship between BMI and medication utilization in migraine

Basic objectives2

Others

Basic objectives -Others

Utilize the health insurance database

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The used amount of acute and prophylactic medicine in accordance with BMI

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with standard insurance diagnosis of headache and/or migraine who are prescribed triptans

Key exclusion criteria

1) Patients with standard insurance diagnosis of primary headache disorders except for migraine and/or tension type headache

2) Patients with standard insurance diagnosis of secondary headache disorders except for medication overuse headache

3) Patients with standard insurance diagnosis of painful cranial neuropathies and/or other facial pain and other headaches

Target sample size

20000


Research contact person

Name of lead principal investigator

1st name Takao
Middle name
Last name TAKESHIMA

Organization

Tominaga Hospital

Division name

Headache center, Department of neurology

Zip code

556-0017

Address

1-4-48 Minatomachi, Naniwa-ku, Osaka-city, Osaka, Japan

TEL

06-6568-1601

Email

ttakeshi@tominaga.or.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name DANNO

Organization

Tominaga Hospital

Division name

Headache center, Department of neurology

Zip code

556-0017

Address

1-4-48 Minatomachi, Naniwa-ku, Osaka-city, Osaka, Japan

TEL

06-6568-1601

Homepage URL


Email

daisuke_danno@yahoo.co.jp


Sponsor or person

Institute

Tominaga Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tominaga Hospital Ethics committee

Address

556-0017 4-48, Minatomachi 1-chome, Naniwa-ku Osaka-city, Osaka

Tel

06-6568-1601

Email

imura@tominaga.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 09 Month 29 Day

Date of IRB

2020 Year 10 Month 14 Day

Anticipated trial start date

2020 Year 10 Month 22 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2020 Year 10 Month 22 Day

Last modified on

2023 Year 08 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048171


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name